
FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma
The Food and Drug Administration (FDA) granted accelerated approval to selinexor for adult patients with…
The Food and Drug Administration (FDA) granted accelerated approval to selinexor for adult patients with…
Treating breast tumours with two cancer drugs simultaneously may prevent endocrine resistance by attacking the…